We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Genticel Launches its Phase II Trial in Women Infected with High-Risk HPV

News   Mar 06, 2014

 
Genticel Launches its Phase II Trial in Women Infected with High-Risk HPV
 
 
Advertisement
 

RELATED ARTICLES

Washington University COVID-19 Virus Effective in Mice

News

An experimental vaccine is effective at preventing pneumonia in mice infected with the COVID-19 virus, according to a study from Washington University School of Medicine in St. Louis

READ MORE

New Treatment Regimens Show Early Efficacy Against Drug-Resistant TB

News

New treatment regimens for multidrug-resistant tuberculosis have shown early effectiveness in 85% of patients in a cohort that included many with serious comorbidities.

READ MORE

Monitoring Skin Cancer Using Molecules in Urine

News

Researchers at Pavol Jozef Šafárik University in Košice, Slovakia, have identified fluorescent molecules in urine that correlate with melanoma progression, creating new possibilities for monitoring the disease.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE